NPB:NYSENorthpointe Bancshares, Inc. Analysis
Data as of 2026-08-28 - not real-time
$17.02
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Northpointe Bancshares, Inc. is priced at $17.02, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 9.4%. RSI sits at 42.8, which reads as neutral, and MACD momentum is bullish. Watch $16.75 as support and $17.87 as the nearer resistance level.
On valuation the read is undervalued — earnings multiple of 7.2 versus a 17.0 sector average, below the peer group. Sell-side targets cluster 19.8% above the current quote. Revenue is growing at 9.8% on a 34.9% profit margin. The 0.58% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 33.1%, a beta of 0.66 and a maximum drawdown of 15.4%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
On valuation the read is undervalued — earnings multiple of 7.2 versus a 17.0 sector average, below the peer group. Sell-side targets cluster 19.8% above the current quote. Revenue is growing at 9.8% on a 34.9% profit margin. The 0.58% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 33.1%, a beta of 0.66 and a maximum drawdown of 15.4%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
Top Market Events
Northpointe Bancshares, Inc. NPB delivered earnings and revenue surprises of -11.77% and -5.50%, respectively, for the...Morningstar%2c Inc.21dNorthpointe Bank Earns National Recognition Across Leadership, Lending, and Workplace...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 17.61
- MACD momentum is positive
- 30-day price change of -9.4%
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 7.2 versus sector average of 17.0
- Trading below the 200-day average of 17.61
- Analyst targets imply +19.8% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 7.2 versus sector average of 17.0
- Analyst targets imply +19.8% versus the current price
- Profit margin of 34.9% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth9.80%
Profit Margin34.88%
P/E Ratio7.2
ROE14.76%
ROA1.29%
P/B Ratio1.0
Op. Cash Flow$103.7M
Industry P/E17.0
Technical Analysis
TrendNeutral
RSI42.8
Support$16.75
Resistance$17.87
MA 20$17.19
MA 50$17.84
MA 200$17.61
MACDBullish
VolumeIncreasing
Fear & Greed Index95.59
Valuation
Fair Value$9.20
Target Price$20.38
Upside/Downside19.76%
GradeUndervalued
TypeBlend
Dividend Yield0.58%
Risk Assessment
Beta0.66
Volatility33.08%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.